Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Ureteral Neoplasms × Cystoscopy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 3 Ureteral Neoplasms 1

Interventions

Specimen Handling 5 Magnetic Resonance Spectroscopy 3 pembrolizumab 2 enfortumab vedotin 2 cabozantinib 2 avelumab 2 Nivolumab 2 Ipilimumab 2 Immunoglobulin G 2 Gemcitabine 2 Disulfides 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 tocilizumab 1 eribulin 1 erdafitinib 1 durvalumab 1 atezolizumab 1 Watchful Waiting 1 Observation 1 Doxorubicin 1 Cystoscopy 1 Contrast Media 1 Cisplatin 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244384 2026-03-19

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡